EP
WST icon

Essential Partners’s West Pharmaceutical WST Stock Holding History

Essential Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.4K Hold
28
– – ﹤0.01% 1182
2026
Q2 		$10.1K Hold
28
– – ﹤0.01% 1212
2026
Q1 		$7.02K Sell
28
-861
-97% -$214K ﹤0.01% 1409
2025
Q4 		$245K Buy
889
+45
+5% +$12.3K 0.08% 283
2025
Q3 		$221K Buy
844
+812
+2,538% +$197K 0.07% 301
2025
Q2 		$7K Buy
+32
New +$6.84K ﹤0.01% 953

Other funds holding WST

Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $343M AUM 13.42% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Tran Capital Management
Tran Capital Management San Rafael, California $873M AUM 51.28% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $636M AUM 19.4% 1-Year Est. Return

Essential Partners's WST Position: Q3 2026 in Review

Essential Partners held its West Pharmaceutical (WST) position steady in Q3 2026 at 28 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

Essential Partners first reported a position in WST in Q2 2025 and has held it in 6 quarters since. The position peaked at $245K in Q4 2025. 118 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Essential Partners held 28 shares of West Pharmaceutical worth $10.4K as of Q3 2026.
  • Essential Partners left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1182 holding.
  • Essential Partners first reported a position in West Pharmaceutical in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's West Pharmaceutical position peaked at $245K in Q4 2025.
  • 118 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.